Inderpal Kalayan possesses extensive experience in clinical trial management within the biopharmaceutical industry, with a focus on virology and chronic kidney disease. Currently serving as a Global Clinical Operations Leader at Roche, Kalayan is involved in a Phase III obesity trial in the cardiovascular and renal metabolic disease (CVRM) therapeutic area. Previous roles include a Global Clinical Study Manager at AstraZeneca, leading teams in global Phase III clinical trials, and a Senior Clinical Trial Manager Associate at Gilead Sciences, managing trials for HIV PrEP and COVID-19 across multiple regions. Kalayan's career also includes significant positions at Vertex Pharmaceuticals, ICON plc, and other notable companies, with a solid academic foundation in Biochemistry from the University of Westminster.
This person is not in the org chart
This person is not in any teams
This person is not in any offices